A MULTICENTER, LONGITUDINAL, PROSPECTIVE, PHARMACOKINETIC,PHASE 1B STUDY IN WOMEN WITH CHRONIC INFLAMMATORY DISEASES TREATED WITHCIMZIA® (CERTOLIZUMAB PEGOL) DURING PREGNANCY

Project: Research project

Project Details

Description

A MULTICENTER, LONGITUDINAL, PROSPECTIVE, PHARMACOKINETIC, PHASE 1B STUDY IN WOMEN WITH CHRONIC INFLAMMATORY DISEASES TREATED WITH CIMZIA® (CERTOLIZUMAB PEGOL) DURING PREGNANCY
StatusActive
Effective start/end date2/26/202/28/24

Funding

  • UCB Pharma S.A.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.